Stephan A Hahn

Title: Innovations of Inventor Stephan A Hahn

Introduction

Stephan A Hahn is a notable inventor based in Wilten, Germany. He has made significant contributions to the field of genetics, particularly in the area of tumor suppressor genes. With a total of 3 patents to his name, his work has implications for diagnosing and treating various cell proliferative disorders.

Latest Patents

Hahn's latest patents focus on the tumor suppressor gene DPC4. The first patent provides polynucleotide and polypeptide sequences encoding this novel tumor suppressor gene. It also includes a method for detecting a cell proliferative disorder associated with DPC4. This gene serves as a valuable marker that can be utilized diagnostically, prognostically, and therapeutically throughout the course of disorders linked to DPC4. The second patent reiterates the importance of DPC4, emphasizing its role in identifying and managing cell proliferative disorders.

Career Highlights

Stephan A Hahn is affiliated with Johns Hopkins University, a prestigious institution known for its research and innovation. His work at the university has allowed him to explore groundbreaking ideas and contribute to advancements in medical science.

Collaborations

Hahn collaborates with Scott E Kern, a fellow researcher who shares his passion for genetic research and innovation.

Conclusion

Stephan A Hahn's contributions to the field of genetics, particularly through his patents related to the DPC4 tumor suppressor gene, highlight his role as an influential inventor. His work continues to pave the way for advancements in the diagnosis and treatment of cell proliferative disorders.